CathyAHelgasonMD

PubMed

• 4 citations
  P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in...
  Kevin Q. Chang, Anita Lwanga, Tanjeev Kaur, Cathy Helgason> ;Cureus. 2018 Aug 4
• 12 citations
  Blood glucose and stroke.
  Cathy M. Helgason> ;Current Treatment Options in Cardiovascular Medicine. 2012 May 8
• 1 citations
  Principled versus statistical thinking in diagnosis and treatment of stroke.
  Cathy M. Helgason, Thomas H. Jobe> ;Current Treatment Options in Cardiovascular Medicine. 2010 Apr 14
• Artificial adaptive systems and fuzzy measures for translation of clinical trial results to the bedside
  Cathy M. Helgason> ;Current Treatment Options in Cardiovascular Medicine. 2009 May 2
• 3 citations
  Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.
  Kathryn M. Momary, Nancy L. Shapiro, Larry D. Brace, Stacy S. Shord, Enzo Grossi, Marlos A. G. Viana, Cathy M. Helgason, Edith A. Nutescu, Larisa H. Cavallari> ;Cerebrovascular Diseases. 2009 May 1
• 2 citations
  Measurable prediction for the single patient and the results of large double blind controlled randomized trials.
  Cathy M. Helgason, Thomas H. Jobe> ;Plos One. 2008 Apr 2
• 68 citations
  Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
  Cathy M. Helgason, Enzo Grossi, Dilip K. Pandey, Aziz Valika, John F. Cursio, Larry D. Brace> ;Cerebrovascular Diseases. 2008 Jan 1
• 59 citations
  Factors influencing warfarin dose requirements in African-Americans.
  Kathryn M. Momary, Nancy L. Shapiro, Marlos A. G. Viana, Edith A. Nutescu, Cathy M. Helgason, Larisa H. Cavallari> ;Pharmacogenomics. 2007 Nov 22
• 8 citations
  Warfarin in patients with stroke and reasons for discontinuation.
  Cathy M. Helgason, Mary Anthu Do, Edith A. Nutescu> ;Journal of Stroke and Cerebrovascular Diseases. 2004 Mar 1
• The difference between a dynamic and mechanical approach to stroke treatment.
  Cathy M. Helgason> ;Current Treatment Options in Cardiovascular Medicine. 2007 May 18
• Carotid Endarterectomy for Asymptomatic Plaque
  Cathy M. Helgason> ;Neurologic Clinics. 2006 Nov 1
• Predictors of recurrent stroke in African Americans.
  Ruland S, Richardson D, Hung E, Brorson JR, Cruz-Flores S, Felton WL, Ford-Lynch G, Helgason C, Hsu C, Kramer J, Mitsias P, Gorelick PB> ;Neurology. 2006-08-22
• 1 citations
  Thrombophilia in ischemic stroke subtypes: implications for treatment.
  Cathy M. Helgason> ;Current Treatment Options in Cardiovascular Medicine. 2006 May 1
• 24 citations
  Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke
  Larisa H. Cavallari, Cathy M. Helgason, Larry D. Brace, Marlos A. G. Viana, Edith A. Nutescu> ;The Annals of Pharmacotherapy. 2006 May 1
• 1 citations
  A fuzzy theory of cortical computation: neuropoietic engrams, fuzzy hypercubes, and the nature of consciousness.
  Francisco Lopez, Thomas H. Jobe, Cathy M. Helgason> ;Medical Hypotheses. 2006 Jan 1
• 7 citations
  Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients
  Cathy M. Helgason, Thomas H. Jobe> ;Current Treatment Options in Cardiovascular Medicine. 2005 Jul 1
• 5 citations
  Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis
  Edith A. Nutescu, Cathy M. Helgason> ;Current Treatment Options in Cardiovascular Medicine. 2005 Jul 1
• 5 citations
  New blood thinner offers first potential alternative in 50 years: ximelagatran.
  Edith A. Nutescu, Cathy M. Helgason, Joan Briller, Dorie W. Schwertz> ;The Journal of Cardiovascular Nursing. 2004 Nov 1
• 9 citations
  The application of fuzzy logic to the prescription of antithrombotic agents in the elderly.
  Cathy M. Helgason> ;Drugs & Aging. 2004 Jan 1
• 4 citations
  Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.
  Edith A. Nutescu, Cathy M. Helgason> ;Pharmacotherapy. 2004 Jul 1
• 6 citations
  Fuzzy logic and causal reasoning with an 'n' of 1 for diagnosis and treatment of the stroke patient.
  Cathy M. Helgason, Thomas H. Jobe> ;Expert Review of Neurotherapeutics. 2004 Mar 1
• The selection of antithrombotic agents in the prevention of recurrent ischemic stroke.
  Cathy M. Helgason> ;Current Cardiology Reports. 2003 Mar 1
• 9 citations
  Measurable Differences between Sequential and Parallel Diagnostic Decision Processes for Determining Stroke Subtype: A Representation of Interacting Pathologies
  Cathy M. Helgason, Fred A. Watkins, Thomas H. Jobe> ;Thrombosis and Haemostasis. 2002 Aug 1
• 10 citations
  Statistical versus fuzzy measures of variable interaction in patients with stroke.
  Cathy M. Helgason, Davender S. Malik, Shih Chuan Cheng, Thomas H. Jobe, John N. Mordeson> ;Neuroepidemiology. 2001 May 9
• 3 citations
  Ischemic stroke pathophysiology.
  James C. Grotta, Cathy Helgason> ;Journal of Stroke and Cerebrovascular Diseases. 1999 May 1
• Join now to see all